Use of dual genomic sequencing to screen mitochondrial diseases in pediatrics: a retrospective analysis

Mitochondrial diseases (MDs) were a large group multisystem disorders, attributable in part to the dual genomic control. The advent of massively sequencing has improved diagnostic rates and speed, and was increasingly being used as a first-line diagnostic test. Paediatric patients (aged 

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Scientific reports 2023-03, Vol.13 (1), p.4193-4193, Article 4193
Hauptverfasser: Wu, Teng-Hui, Peng, Jing, Yang, Li, Chen, Yan-Hui, Lu, Xiu-Lan, Huang, Jiao-Tian, You, Jie-Yu, Ou-Yang, Wen-Xian, Sun, Yue-Yu, Xue, Yi-Nan, Mao, Xiao, Yan, Hui-Ming, Ren, Rong-Na, Xie, Jing, Chen, Zhi-Heng, Zhang, Victor-Wei, Lyu, Gui-Zhen, He, Fang
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Mitochondrial diseases (MDs) were a large group multisystem disorders, attributable in part to the dual genomic control. The advent of massively sequencing has improved diagnostic rates and speed, and was increasingly being used as a first-line diagnostic test. Paediatric patients (aged 
ISSN:2045-2322
2045-2322
DOI:10.1038/s41598-023-31134-5